Your browser doesn't support javascript.
loading
Axl as a potential therapeutic target for adamantinomatous craniopharyngiomas: Based on single nucleus RNA-seq and spatial transcriptome profiling.
Chen, Yiguang; Liu, Xiaohai; Ainiwan, Yilamujiang; Li, Mingchu; Pan, Jun; Chen, Yongjian; Xiao, Zebin; Wang, Ziyu; Xiao, Xinru; Tang, Jie; Zeng, Gao; Liang, Jiantao; Su, Xin; Kungulli, Roberta; Fan, Yuxiang; Lin, Qingtang; Liya, A; Zheng, Yifeng; Chen, Zexin; Xu, Canli; Zhang, Hongqi; Chen, Ge.
Afiliação
  • Chen Y; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China; Department of Neurosurgery, Nanfang Hospital, Southern Medical University, No.
  • Liu X; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • Ainiwan Y; Department of Neurosurgery, Nanfang Hospital, Southern Medical University, No. 1838, Guangzhou North Road, Guangzhou, Guangdong, 510515, China.
  • Li M; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • Pan J; Department of Neurosurgery, Nanfang Hospital, Southern Medical University, No. 1838, Guangzhou North Road, Guangzhou, Guangdong, 510515, China.
  • Chen Y; Dermatology and Venereology Division, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institute, Stockholm, 10005, Sweden.
  • Xiao Z; Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, China.
  • Wang Z; Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital Capital Medical University, National Clinical Research Center for Geriatric Diseases and Key Laboratory of Neurodegenerative Diseases, Ministry of Education, Beijing, 100053, China.
  • Xiao X; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • Tang J; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • Zeng G; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • Liang J; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • Su X; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • Kungulli R; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • Fan Y; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • Lin Q; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China.
  • Liya A; Guangdong Research Center of Organoid Engineering and Technology, Guangzhou, 510535, China.
  • Zheng Y; Guangdong Research Center of Organoid Engineering and Technology, Guangzhou, 510535, China.
  • Chen Z; Guangdong Research Center of Organoid Engineering and Technology, Guangzhou, 510535, China.
  • Xu C; Guangdong Research Center of Organoid Engineering and Technology, Guangzhou, 510535, China.
  • Zhang H; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. Electronic address: zhanghongqi@xwhosp.org.
  • Chen G; Department of Neurosurgery, Xuanwu Hospital Capital Medical University, Beijing, 100053, China; China International Neuroscience Institute (China-INI), Xuanwu Hospital, Capital Medical University, Beijing, 100053, China. Electronic address: chenyiguang@mail.ccmu.edu.cn.
Cancer Lett ; 592: 216905, 2024 Jun 28.
Article em En | MEDLINE | ID: mdl-38677641

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Proteínas Proto-Oncogênicas / Receptores Proteína Tirosina Quinases / Craniofaringioma / Microambiente Tumoral / Receptor Tirosina Quinase Axl Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Hipofisárias / Proteínas Proto-Oncogênicas / Receptores Proteína Tirosina Quinases / Craniofaringioma / Microambiente Tumoral / Receptor Tirosina Quinase Axl Idioma: En Ano de publicação: 2024 Tipo de documento: Article